A randomized comparison of quadruple and triple therapies for Helicobacter pylori eradication: The QUADRATE study

Gastroenterology

Volumn 123, Issue 6, 2002, Pages 1763-1769

  Katelaris, Peter H ^a   Forbes, Geoffrey M ^b   Talley, Nicholas J ^a   Crotty, Brendan ^c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL PERTH HOSPITAL   (Australia)

^c AUSTIN HEALTH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; BISMUTH; BISMUTH CITRATE; CLARITHROMYCIN; METRONIDAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR; TETRACYCLINE;

ABDOMINAL PAIN; ADULT; AGED; ANOREXIA; ANTIBIOTIC RESISTANCE; ARTICLE; CANDIDIASIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOSE RESPONSE; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ERADICATION THERAPY; FECES COLOR; FEMALE; HEADACHE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; TASTE DISORDER; TONGUE DISEASE; UREA BREATH TEST; VOMITING;

EID: 0036892319     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2002.37051     Document Type: Article

References (27)

1. Axon AT. Helicobacter pylori therapy: Effect on peptic ulcer disease. J Gastroenterol Hepatol 1991;6:131-137.
2. European Helicobacter pylori Study Group. Current European concepts on the management of Helicobacter pylori infection. The Maastricht Consensus Report. Gut 1997;41:8-13.
3. Huang J, Hunt RH. The importance of clarithromycin dose in the management of Helicobacter pylori infection: A meta-analysis of triple therapies with a proton pump inhibitor, clarithromycin and amoxycillin or metronidazole. Aliment Pharmacol Ther 1999;13:719-729.
4. Gisbert JP, Gonzalez L, Calvet X, Garcia N, Lopez T, Roque M, Gabriel R, Pajares RM. Proton pump inhibitor, clarithromycin and either amoxycillin or nitroimidazole: A meta-analysis of eradication of Helicobacter pylori. Aliment Pharmacol Ther 2000;14:1319-1328.
5. Proceedings of the American Digestive Health Foundation International Update Conference on Helicobacter pylori. Gastroenterology 1997;113:S1-S169.
6. van der Wouden EJ, Thijs JC, van Zwet AA, Slulter WJ, Kleibeuker JH. The influence of in vitro nitroimidazole resistance on the efficacy of nitroimidazole-containing anti-Helicobacter pylori regimens: A meta-analysis. Am J Gastroenterol 1999;94:1751-1759.
7. de Boer WA, Driessen WM, Potters VP, Tytgat GN. Randomized study comparing 1 with 2 weeks of quadruple therapy for eradicating Helicobacter pylori. Am J Gastroenterol 1994;89:1993-1997.
8. Houben MH, Van Der Beek D, Hensen EF, Craen AJ, Rauws EA, Tytgat GN. A systematic review of Helicobacter pylori eradication therapy - The impact of antimicrobial resistance on eradication rates. Aliment Pharmacol Ther 1999;13:1047-1055.
9. Katelaris PH, Nguyen TV, Robertson G, Bradbury R, Ngu MC. Prevalence and demographic determinants of metronidazole resistance by Helicobacter pylori in a large cosmopolitan cohort of Australian dyspeptic patients. Aust N Z J Med 1998;28:633-638.
10. Osato MS, Reddy R, Graham DY. Metronidazole and clarithromycin resistance amongst Helicobacter pylori isolates from a large metropolitan hospital in the United States. Int J Antimicrob Agents 1999;12:341-347.
11. Wang WH, Wong BC, Mukhopadhyay AK, Berg DE, Cho CH, Lai KC, Hu WH, Fung FM, Hui WM, Lam SK. High prevalence of Helicobacter pylori infection with dual resistance to metronidazole and clarithromycin in Hong Kong. Aliment Pharmacol Ther 2000;14:901-910.
12. Dore MP, Leandro G, Realdi G, Sepulveda AR, Graham DY. Effect of pretreatment antibiotic resistance to metronidazole and clarithromycin on outcome of Helicobacter pylori therapy: A meta-analytical approach. Dig Dis Sci 2000;45:68-76.
13. Delaney B, Moayyedi P, Deeks J, et al. The management of dyspepsia: A systematic review. Health Technol Assess 2000;4:1-189.
14. Veldhuyzen van Zanten SJ, Flook N, Chiba N, et al. An evidence-based approach to the management of uninvestigated dyspepsia in the era of Helicobacter pylori. Canadian Dyspepsia Working Group. CMAJ 2000;162(suppl 12):S3-S23.
15. Talley NJ. How should Helicobacter pylori positive dyspeptic patients be managed? Gut 1999;45(suppl 1):128-131.
16. Katelaris PH, Adamthwaite D, Midolo P, Yeomans N, Davidson G, Lambert J. Randomized trial of omeprazole and metronidazole with either amoxycillin or clarithromycin for the eradication of H. pylori in a region of high metronidazole resistance - The HERO study. Aliment Pharmacol Ther 2000;14:751-758.
17. Laine L, Fennerty MB, Osato M, et al. Esomeprazole-based Helicobacter pylori eradication therapy and the effect of antibiotic resistance: Results of three US multicenter, double-blind trials. Am J Gastroenterol 2000;95:3393-3398.
18. Lind T, van Zanten Veldhuyzen S, Unge P, et al. Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: The MACH 1 study. Helicobacter 1996;1:138-144.
19. Lind T, Megraud F, Unge P, et al. The MACH 2 study: Role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies. Gastroenterology 1999;116:248-253.
20. Broutet N, Tchamgoue S, Pereira E, Lamouliatte H, Megraud F. Failure of Helicobacter pylori therapy: Disparity between duodenal ulcer and non-ulcer dyspepsia. Gut 2000;47(suppl 1):A101.
21. Working Party of the European Helicobacter Study Group. Guidelines for clinical trials in H. pylori infection. Gut 1997;41(suppl 2):S10-S18.
22. Glupczynski Y, Megraud F, Lopez-Brea M, Andersen LP. European multicentre survey of in vitro antimicrobial resistance in Helicobacter pylori. Eur J Clin Microbiol Infect Dis 2001;20:820-823.
23. Osato MS, Reddy R, Reddy SG, Penland RL, Graham DY. Comparison of the E-test and the NCCLS-approved agar dilution method to detect metronidazole and clarithromycin resistant Helicobacter pylori. Int J Antimicrob Agents 2001;17:39-44.
24. McNulty C, Owen R, Tompkins D, et al. Helicobacter pylori susceptibility testing by disc diffusion. J Antimicrob Chemother 2002;49:601-609.
25. Forbes GM, Collins BJ, McCullough CA, Coombs GW, Robins PD. Short duration therapy for Helicobacter pylori in Western Australia: The impact of metronidazole resistance. Aust N Z J Med 1998;28:13-17.
26. Katelaris PH, Nguyen TV, Robertson G. Efficacy of repeat treatments after initial failure of Helicobacter pylori eradication therapy (abstr). Gastroenterology 1999;116:A205.
27. Michopoulos S, Tsibouris P, Bouzakis H, et al. Randomized study comparing omeprazole with ranitidine as anti-secretory agents combined in quadruple second-line Helicobacter pylori eradication regimens. Aliment Pharmacol Ther 2000;14:737-744.